1. Home
  2. LAR vs SVRA Comparison

LAR vs SVRA Comparison

Compare LAR & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAR
  • SVRA
  • Stock Information
  • Founded
  • LAR 2007
  • SVRA 2007
  • Country
  • LAR Switzerland
  • SVRA United States
  • Employees
  • LAR N/A
  • SVRA N/A
  • Industry
  • LAR
  • SVRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • LAR
  • SVRA Health Care
  • Exchange
  • LAR NYSE
  • SVRA Nasdaq
  • Market Cap
  • LAR 409.6M
  • SVRA 433.8M
  • IPO Year
  • LAR N/A
  • SVRA N/A
  • Fundamental
  • Price
  • LAR $2.95
  • SVRA $2.66
  • Analyst Decision
  • LAR Buy
  • SVRA Buy
  • Analyst Count
  • LAR 1
  • SVRA 5
  • Target Price
  • LAR $3.00
  • SVRA $5.60
  • AVG Volume (30 Days)
  • LAR 1.6M
  • SVRA 1.3M
  • Earning Date
  • LAR 08-11-2025
  • SVRA 08-11-2025
  • Dividend Yield
  • LAR N/A
  • SVRA N/A
  • EPS Growth
  • LAR N/A
  • SVRA N/A
  • EPS
  • LAR N/A
  • SVRA N/A
  • Revenue
  • LAR N/A
  • SVRA N/A
  • Revenue This Year
  • LAR N/A
  • SVRA N/A
  • Revenue Next Year
  • LAR N/A
  • SVRA N/A
  • P/E Ratio
  • LAR N/A
  • SVRA N/A
  • Revenue Growth
  • LAR N/A
  • SVRA N/A
  • 52 Week Low
  • LAR $1.71
  • SVRA $1.89
  • 52 Week High
  • LAR $3.96
  • SVRA $4.74
  • Technical
  • Relative Strength Index (RSI)
  • LAR N/A
  • SVRA 62.60
  • Support Level
  • LAR N/A
  • SVRA $2.25
  • Resistance Level
  • LAR N/A
  • SVRA $2.39
  • Average True Range (ATR)
  • LAR 0.00
  • SVRA 0.16
  • MACD
  • LAR 0.00
  • SVRA 0.05
  • Stochastic Oscillator
  • LAR 0.00
  • SVRA 70.00

About LAR LITHIUM ARGENTINA AG

Lithium Argentina is a pure-play lithium producer. The company owns two neighboring lithium brine resources in northwest Argentina: Cauchari-Olaroz and Pastos Grandes. Cauchari-Olaroz entered production in 2023, while Pastos Grandes is still in development. Lithium Argentina plans for both resources to be fully integrated with onside downstream processing capabilities and will sell into the lithium chemical market.

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Share on Social Networks: